Loxo Oncology, Inc. 4
4 · Loxo Oncology, Inc. · Filed Jun 23, 2017
Insider Transaction Report
Form 4
Naider Avi Z.
Director
Transactions
- Award
Director Stock Option (right to buy)
2017-06-22+11,000→ 11,000 totalExercise: $78.58Exp: 2027-06-21→ Common Stock (11,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 12 equal monthly installments beginning one month after the grant date, until such time as the option is 100% vested, subject to the continuing service of the Reporting Person on each vesting date.